CDDW Abstracts 2012 TOC
Return to Main Menu
Search CDDW Abstracts 2012
Viral Hepatitis Session 2
A022 - SHP-2 PROTECTS INTESTINAL EPITHELIAL CELLS AGAINST ONCOGENIC STRESS BY INDUCING SENESCENCE
A023 - FUTILITY RULES IN TELAPREVIR COMBINATION TREATMENT
A024 - REALIZE TRIAL FINAL RESULTS: TELAPREVIR-BASED REGIMEN FOR GENOTYPE 1 HEPATITIS C VIRUS INFECTIO...
A025 - SUSTAINED VIROLOGIC RESPONSE RATES AND VIRAL RESISTANCE PROFILES IN PATIENTS TREATED WITH A TEL...
A026 - RESPONSE-GUIDED TELAPREVIR COMBINATION TREATMENT IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WHO...
A027 - TELAPREVIR COMBINATION WITH PEGINTERFERON ALFA-2A/RIBAVIRIN IN HCV/HIV COINFECTED PATIENTS: 24-...
A028 - INTRAOCULAR COMPLICATIONS DURING ANTIVIRAL THERAPY FOR HEPATITIS C ARE COMMON AND MORE FREQUENT...